MERRIMACK PHARMACEUTICALS IN

CUSIP: 590328209 Class: Common Stock

Bronte Capital Management Pty Ltd.'s Holding History (CIK: 0001471085)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 578,313 Value ($000) $3,441 Avg Close — Range —
Q1 2022
Shares 578,313 Value ($000) $3,658 Avg Close — Range —
Q4 2021
Shares 537,584 Value ($000) $2,102 Avg Close — Range —
Q3 2021
Shares 548,836 Value ($000) $2,651 Avg Close — Range —
Q2 2021
Shares 548,836 Value ($000) $3,507 Avg Close — Range —
Q1 2021
Shares 550,679 Value ($000) $3,458 Avg Close — Range —
Q4 2020
Shares 531,510 Value ($000) $3,662 Avg Close — Range —
Q3 2020
Shares 531,510 Value ($000) $2,052 Avg Close — Range —